Tsuchiura, Japan

Yoshitada Notsu

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshitada Notsu. Retrieved from https://idiyas.com/inventor/yoshitada-notsu-p5qs4cwj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshitada Notsu

Introduction

Yoshitada Notsu is a notable inventor based in Tsuchiura, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of complex health conditions. His work has led to the development of innovative therapeutic solutions that address critical health issues.

Latest Patents

Yoshitada Notsu holds 1 patent for a prophylactic and therapeutic composition aimed at treating disseminated intravascular coagulation and chronic respiratory tract infectious diseases. His patent describes a method for therapy that involves administering an effective dose of WS7622A mono- or di-sulfate ester or their pharmaceutically acceptable salt to patients in need of treatment.

Career Highlights

Notsu is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His expertise in therapeutic compositions has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Yoshitada Notsu has collaborated with esteemed colleagues, including Noriaki Inamura and Hiroshi Hatanaka. These partnerships have fostered innovation and contributed to the success of various projects within the pharmaceutical sector.

Conclusion

Yoshitada Notsu's contributions to medical innovation highlight the importance of research and collaboration in developing effective treatments for complex health conditions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…